首页> 外文期刊>The Journal of biological chemistry >Aberrant Overexpression of the Rgl2 Ral Small GTPase-specific Guanine Nucleotide Exchange Factor Promotes Pancreatic Cancer Growth through Ral-dependent and Ral-independent Mechanisms
【24h】

Aberrant Overexpression of the Rgl2 Ral Small GTPase-specific Guanine Nucleotide Exchange Factor Promotes Pancreatic Cancer Growth through Ral-dependent and Ral-independent Mechanisms

机译:异常过表达rgl2 ral小gtpase特异性鸟嘌呤核苷酸交换因子通过ral依赖性和无关的机制促进胰腺癌生长

获取原文
           

摘要

Our recent studies established essential and distinct roles for RalA and RalB small GTPase activation in K-Ras mutant pancreatic ductal adenocarcinoma (PDAC) cell line tumorigencity, invasion, and metastasis. However, the mechanism of Ral GTPase activation in PDAC has not been determined. There are four highly related mammalian RalGEFs (RalGDS, Rgl1, Rgl2, and Rgl3) that can serve as Ras effectors. Whether or not they share distinct or overlapping functions in K-Ras-mediated growth transformation has not been explored. We found that plasma membrane targeting to mimic persistent Ras activation enhanced the growth-transforming activities of RalGEFs. Unexpectedly, transforming activity did not correlate directly with total cell steady-state levels of Ral activation. Next, we observed elevated Rgl2 expression in PDAC tumor tissue and cell lines. Expression of dominant negative Ral, which blocks RalGEF function, as well as interfering RNA suppression of Rgl2, reduced PDAC cell line steady-state Ral activity, growth in soft agar, and Matrigel invasion. Surprisingly, the effect of Rgl2 on anchorage-independent growth could not be rescued by constitutively activated RalA, suggesting a novel Ral-independent function for Rgl2 in transformation. Finally, we determined that Rgl2 and RalB both localized to the leading edge, and this localization of RalB was dependent on endogenous Rgl2 expression. In summary, our observations support nonredundant roles for RalGEFs in Ras-mediated oncogenesis and a key role for Rgl2 in Ral activation and Ral-independent PDAC growth.
机译:我们最近的研究在K-RAS突变体胰腺导管腺癌腺癌(PDAC)细胞系肿瘤,侵袭和转移中,为RALA和RALB小GTP酶活性建立了必不可少的角色。然而,尚未确定PDAC中的RAL GTP酶活化的机制。有四种高度相关的哺乳动物Ralgefs(Ralgds,rgl1,rgl2和rgl3),可以作为RAS效应器。它们是否在K-RAS介导的增长转型中共享不同或重叠的功能。我们发现靶向模拟持久性RAS活化的血浆膜增强了RALGEF的生长转化活性。出乎意料的是,转化活性与总细胞稳态水平直接相关的RAL激活。接下来,我们观察到PDAC肿瘤组织和细胞系中的RGL2表达升高。显性负RAL的表达,其阻断RALGEF功能,以及干扰RGL2的RNA抑制,降低PDAC细胞系稳态RAL活性,软琼脂生长,和基质侵袭。令人惊讶的是,通过组成型活化的RAL,不能救出RGL2对锚固无关的生长的影响,这表明RGL2在转化中的rgl2的新颖函数。最后,我们确定rgl2和ralb均归到前沿,而这种RALB的本地化依赖于内源性RGL2表达。总之,我们的观察结果支持RALGEF在RAS介导的癌症中的非冗余作用以及RGL2在RAL活化和RAL无关的PDAC生长中的关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号